Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Eating high levels of flavonoids found in berries, tea, and chocolate offer protection from type 2 diabetes

Eating high levels of flavonoids including anthocyanins and other compounds (found in berries, tea, and chocolate) could offer protection from type 2 diabetes - according to research from the University of East Anglia (UEA) and King's College London.

20 Jan 2014

FDA approves New Drug Application for PENNSA 2%

Mallinckrodt today announced that the U.S. Food and Drug Administration has approved the New Drug Application for PENNSAID (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal anti-inflammatory drug approved for use in the treatment of the pain of osteoarthritis of the knee(s).

17 Jan 2014

U of T researchers find no evidence to support 'blood-type' diet theory

Researchers from the University of Toronto have found that the theory behind the popular blood type diet--which claims an individual's nutritional needs vary by blood type--is not valid. The findings are published this week in PLoS One.

17 Jan 2014

Researchers receive $8M grant to expand research in arsenic toxicity in children, pregnant women

The Children's Environmental Health and Disease Prevention Research Center at Dartmouth and its partner universities have received an $8 million grant to expand their research into arsenic toxicity in children and pregnant women.

17 Jan 2014

Traditional Chinese herbal medicines hold promise for slowing progression of diabetes

Traditional Chinese herbal medicines hold promise for slowing the progression from prediabetes to an official diabetes diagnosis, according to new research accepted for publication in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

17 Jan 2014

New discovery has potential to transform heart attack treatments

An Australian discovery has the potential to transform the treatment of a heart attack, after a new approach boosted heart function and reduced heart scarring in preclinical studies.

16 Jan 2014

US underestimated its progress in war on cancer, say Dartmouth researchers

Since the enactment of the National Cancer Act in 1971, the U.S. has spent hundreds of billions of dollars in cancer research and treatment. And yet, the cancer mortality rate-the historic benchmark of progress-has only declined modestly while the mortality rates of other leading causes of death have declined substantially. This difference has led many to question whether we've made progress in the 'War on Cancer'. The answer is definitively yes according to Norris Cotton Cancer Center research published Monday in the Journal of Clinical Oncology.

16 Jan 2014

People who decrease sitting time and increase physical activity have lower risk of chronic disease

People who decrease sitting time and increase physical activity have a lower risk of chronic disease, according to Kansas State University research.

16 Jan 2014

Prolonged sedentary time linked with premature mortality in women

A woman's body at rest will remain at rest - and that means health woes for older women. Led by Cornell University nutritional scientist Rebecca Seguin, a new study of 93,000 postmenopausal American women found those with the highest amounts of sedentary time - defined as sitting and resting, excluding sleeping - died earlier than their most active peers.

16 Jan 2014

New way to improve lipid profiles in patients undergoing hemodialysis may prevent heart attack

Researchers at Wayne State University have discovered a potential way to improve the lipid profiles in patients undergoing hemodialysis that may prevent cardiovascular disease common in these patients.

16 Jan 2014

PGC-1α protein found in muscle may contributes to the development of type 2 diabetes later in life

A Montr-al research team led by Jennifer Estall at the IRCM discovered that a protein found in muscle tissue may contribute to the development of type 2 diabetes later in life. The study's results, published in today's printed edition of the scientific journal American Journal of Physiology - Endocrinology and Metabolism, indicate that the protein could be a promising early predictor of increased diabetes risk.

15 Jan 2014

First commercial implant of Elixir's DESolve Novolimus Eluting Coronary Scaffold performed in Germany

Marking a milestone in the evolution of fully-bioresorbable drug-eluting scaffolds for interventional cardiology, the first commercial implant of Elixir Medical's CE Mark-approved DESolve Novolimus Eluting Coronary Scaffold was performed in Germany by Professor Dr. med. Holger Nef, Head of the Cardiac Catheterization Laboratory, University Hospital Giessen, Giessen, Germany.

15 Jan 2014

FDA accepts Iroko Pharmaceuticals' ZORVOLEX sNDA for review

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration has accepted for review the Supplemental New Drug Application for ZORVOLEX (diclofenac), a lower dose nonsteroidal anti-inflammatory drug, for the proposed indication of treatment of osteoarthritis pain in adults. ZORVOLEX was approved by FDA in October 2013 for the treatment of mild to moderate acute pain in adults.

15 Jan 2014

Cardiovascular conditions may be overlooked in bipolar disorder

Cardiovascular comorbidities may be going under-recognized and undertreated in patients with bipolar disorder, say UK researchers.

10 Jan 2014

Men who are fit and obese run higher risk of having heart attack than unfit, lean men

In a study published in the European Heart Journal, a research team at Ume- University, Sweden, has shown that physical fitness in your teens can reduce the risk of heart attack later in life, while men who are fit and obese in their teens run a higher risk of having a heart attack than unfit, lean men.

10 Jan 2014

Radius Medical launches new PRODIGY Support Catheter in the U.S.

Radius Medical, LLC. today announced the FDA clearance and product launch of its new PRODIGY™ Support Catheter. Engineered to provide back up support to the guidewire when encountering difficult to cross lesions, the PRODIGY Support catheter will be a critical component in the revolutionary techniques now being developed in treating chronic total occlusions.

10 Jan 2014

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

Gastric bypass surgery is a type of bariatric operation that results in weight loss and stimulates metabolic effects that treat diabetes and other cardiovascular risk factors such as diabetes, high cholesterol, and hypertension.

9 Jan 2014

Research opens door to new direction of PAH treatment

The development of new, more effective vasodilators to treat pulmonary arterial hypertension has been hampered because of their systemic toxicity and adverse side effects. An international team of investigators seeking to surmount these problems and increase drug efficacy have determined that a vascular homing peptide can selectively target hypertensive pulmonary arteries to boost the pulmonary but not systemic effects of vasodilators. Importantly for potential clinical use, this peptide retains its activity when given sublingually. The results using a rat model of PAH are published in the American Journal of Pathology.

8 Jan 2014

Crowdsourcing fungal metabolites with antitumor activity: an interview with Dr. Robert H. Cichewicz, University of Oklahoma

Fungi have played a large role in the development of many important drugs that are in wide use today. The most well-known of these are the penicillins.

7 Jan 2014

Barostim Therapy: A cost-effective treatment for patients with drug resistant hypertension

CVRx, Inc., a privately held medical device company, today announced findings from a health-economic analysis published in the Journal of Hypertension that indicates Barostim Therapy is a cost-effective treatment option for patients with drug resistant hypertension.

7 Jan 2014

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Eating high levels of flavonoids found in berries, tea, and chocolate offer protection from type 2 diabetes

FDA approves New Drug Application for PENNSA 2%

U of T researchers find no evidence to support 'blood-type' diet theory

Researchers receive $8M grant to expand research in arsenic toxicity in children, pregnant women

Traditional Chinese herbal medicines hold promise for slowing progression of diabetes

New discovery has potential to transform heart attack treatments

US underestimated its progress in war on cancer, say Dartmouth researchers

People who decrease sitting time and increase physical activity have lower risk of chronic disease

Prolonged sedentary time linked with premature mortality in women

New way to improve lipid profiles in patients undergoing hemodialysis may prevent heart attack

PGC-1α protein found in muscle may contributes to the development of type 2 diabetes later in life

First commercial implant of Elixir's DESolve Novolimus Eluting Coronary Scaffold performed in Germany

FDA accepts Iroko Pharmaceuticals' ZORVOLEX sNDA for review

Cardiovascular conditions may be overlooked in bipolar disorder

Men who are fit and obese run higher risk of having heart attack than unfit, lean men

Radius Medical launches new PRODIGY Support Catheter in the U.S.

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

Research opens door to new direction of PAH treatment

Crowdsourcing fungal metabolites with antitumor activity: an interview with Dr. Robert H. Cichewicz, University of Oklahoma

Barostim Therapy: A cost-effective treatment for patients with drug resistant hypertension

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in